We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+8.9%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$14.2B
AUM Growth
+$847M
(+6.3%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
19.5%
Holding
276
New
33
Increased
93
Reduced
113
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Conagra Brands
CAG
|
+$127M |
| 2 |
Wells Fargo
WFC
|
+$107M |
| 3 |
Netflix
NFLX
|
+$104M |
| 4 |
Charter Communications
CHTR
|
+$97.8M |
| 5 |
NXP Semiconductors
NXPI
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$115M |
| 2 |
DuPont de Nemours
DD
|
+$115M |
| 3 |
Constellation Brands
STZ
|
+$107M |
| 4 |
Broadcom
AVGO
|
+$105M |
| 5 |
CMA
Comerica
CMA
|
+$92.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.28% |
| 2 | Healthcare | 16.57% |
| 3 | Industrials | 13.2% |
| 4 | Consumer Discretionary | 12.77% |
| 5 | Financials | 11.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
National Vision
EYE
$1.8B
| $21.4M | 0.15% |
474,625
-14,770
| -3% | -$623K |
|
|
WMGI
177
DELISTED
Wright Medical Group Inc
WMGI
| $20.9M | 0.15% |
720,576
-222,405
| -24% | -$5.99M |
|
|
WNS
178
DELISTED
WNS Holdings
WNS
| $20.7M | 0.15% |
408,595
+14,995
| +4% | +$766K |
|
179
Watsco Inc
WSO
$13.2B
| $20.4M | 0.14% |
114,290
-995
| -0.9% | -$176K |
|
180
Advanced Energy
AEIS
$13B
| $19.9M | 0.14% |
386,003
-4,870
| -1% | -$282K |
|
181
DexCom
DXCM
$31.3B
| $19.7M | 0.14% |
+551,168
| New | +$17.1M |
|
182
Arista Networks
ANET
$242B
| $19.3M | 0.14% |
+1,160,336
| New | +$19.8M |
|
|
CLVS
183
DELISTED
Clovis Oncology, Inc.
CLVS
| $19.2M | 0.13% |
653,658
-148,410
| -19% | -$5.75M |
|
|
CORV
184
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $19.2M | 0.13% |
4,774,149
+146,195
| +3% | +$645K |
|
185
Lincoln Electric
LECO
$15.2B
| $19.2M | 0.13% |
+204,980
| New | +$19M |
|
186
H.B. Fuller
FUL
$3.18B
| $18M | 0.13% |
348,794
-136,246
| -28% | -$7.7M |
|
187
Nektar Therapeutics
NKTR
$2.48B
| $16.2M | 0.11% |
17,684
-30,386
| -63% | -$25.9M |
|
188
Sarepta Therapeutics
SRPT
$1.77B
| $15.3M | 0.11% |
+94,655
| New | +$12.9M |
|
189
Alnylam Pharmaceuticals
ALNY
$28.9B
| $15M | 0.11% |
170,855
-57,285
| -25% | -$5.76M |
|
|
XENT
190
DELISTED
Intersect ENT, Inc
XENT
| $13.6M | 0.1% |
474,282
+12,750
| +3% | +$383K |
|
191
Fate Therapeutics
FATE
$290M
| $13.6M | 0.1% |
832,070
+26,610
| +3% | +$315K |
|
192
Viavi Solutions
VIAV
$10B
| $13.3M | 0.09% |
+1,175,395
| New | +$12.7M |
|
|
KYNB
193
Kyntra Bio
KYNB
$28.3M
| $12.7M | 0.09% |
8,383
-84
| -1% | -$129K |
|
|
UCTT
194
Ultra Clean Holdings
UCTT
$3.76B
| $12.7M | 0.09% |
1,011,698
+121,415
| +14% | +$1.77M |
|
195
Evolent Health
EVH
$404M
| $11.8M | 0.08% |
+416,980
| New | +$9.95M |
|
|
APLS
196
DELISTED
Apellis Pharmaceuticals
APLS
| $10.9M | 0.08% |
612,296
+5,340
| +0.9% | +$98.7K |
|
197
Floor & Decor
FND
$6.39B
| $10.8M | 0.08% |
358,246
-145,945
| -29% | -$5.95M |
|
198
NovoCure
NVCR
$1.83B
| $10.8M | 0.08% |
205,805
-303,805
| -60% | -$12.1M |
|
|
NEWR
199
DELISTED
New Relic, Inc.
NEWR
| $10.7M | 0.08% |
114,074
-114,040
| -50% | -$11.8M |
|
200
Camden Property Trust
CPT
$11B
| $10.5M | 0.07% |
111,931
-125,564
| -53% | -$11.7M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q3 2018 Portfolio in Review
As of Q3 2018, Westfield Capital Management held 276 positions worth $14.2B, up 6.3% from $13.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Westfield Capital Management's Q3 2018 filing shows 33 new, 93 increased, 113 reduced and 27 closed positions. Its largest new stake was Wells Fargo: 1,878,284 shares worth $98.7M. The largest sale was Meta Platforms (Facebook), an estimated $115M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Westfield Capital Management's largest Q3 2018 buy was Wells Fargo: 1,878,284 shares worth $98.7M.
- Westfield Capital Management added most to Conagra Brands in Q3 2018, an estimated $127M increase.
- Westfield Capital Management's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $115M.
- Westfield Capital Management fully exited Broadcom in Q3 2018, selling an estimated $105M.
- Westfield Capital Management's ten largest holdings make up 20% of its $14.2B portfolio in Q3 2018.
- Westfield Capital Management opened 33 new positions and closed 27 in Q3 2018.
- Westfield Capital Management's portfolio value rose 6.3% quarter-over-quarter to $14.2B.
Based on Westfield Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.